Toggle Side Panel

Injection to protect premature babies from RSV

max
MariaPCC 22 July 2025

Premature babies at risk of life-threatening infection can be protected against the common respiratory syncytial virus (RSV) this winter, with a single long-lasting injection available on the NHS for the first time. The NHS in England is rolling out drug nirsevimab from late September to provide protection against RSV to around 7,000 high-risk infants and babies born before 32 weeks, helping hundreds of the most vulnerable infants avoid hospitalisation. Nirsevimab – which offers six months’ protection in a single dose – will replace monthly injections of palivizumab previously offered to a smaller number of vulnerable babies.

Categories: News

Report

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .
Keep up to date

Sign up to receive our daily news alerts straight to your inbox. Subscribe to our weekly newsletter containing a summary of the week’s news, blog and vote on our poll.

Weekly Newsletter

Daily news updates

Have a discussion

Help keep the conversation going between meetings by creating a forum to hold discussions with your members. It’s an easy way to manage and communicate with members.

Create a network

Create a network to share documents, knowledge and best practice with your colleagues. Set up a network to keep in touch with other people in your organisation or with shared interest groups across organisational boundaries.

Networks can be open to all or available only to a closed group defined by the administrator.

Join or create a network here.